Table 3. Contribution of biochemical and physical variables to a model predicting infection in systemically inflamed neutropenic hematology patients.
Variable | Patient group with highest level of analyte | Included in model | |||
Name | Short name | Impor-tancea | 55-variable | 40-variable | |
S-Procalcitonin | Procalc | 2.5 | Infectedb | X | X |
S-Urea | Urea | 2.3 | Non-infectedb | X | X |
B-White blood cell count | WBC | 2.3 | Infected | X | X |
S-Interleukin-10 | IL-10 | 2.2 | Infected | X | X |
S-Bilirubin | Bil | 2.0 | Infected | X | X |
S-Interleukin-8 | IL-8 | 1.9 | Infected | X | X |
P-Factor XII (Hageman factor) | XII | 1.9 | Non-infected | X | X |
B-Erythrocyte volume fraction | EVF | 1.8 | Non-infected | X | X |
S-Bilirubin (conjugated) | BilC | 1.8 | Infected | X | X |
B-Hemoglobin | Hb | 1.7 | Non-infected | X | X |
Current smoker | Smok | 1.7 | Non-infected | X | X |
S-Cortisol | Cort | 1.7 | Infected | X | X |
B-Lymphocyte count | Lymph | 1.6 | Non-infected | X | |
P-Plasminogen activator inhibitor-1 | PAI | 1.6 | Infected | X | X |
P-von Willebrand factor | vWF | 1.6 | Infected | X | X |
S-High mobility group box protein-1 | HMGB | 1.6 | Non-infected | X | X |
S-Prohepcidin | Prohep | 1.5 | Infected | X | X |
S-Low-density lipoprotein | LDL | 1.5 | Non-infected | X | X |
B-Neutrophil count | Neu | 1.5 | Non-infected | X | |
S-C4b-binding protein (β-chain-containing isoform) | C4BPb | 1.4 | Non-infected | X | X |
S-Cystatin C | CysC | 1.4 | Infected | X | X |
P-Glucose | Glu | 1.4 | Infected | X | |
P-Protein S | Prot S | 1.4 | Non-infected | X | X |
Cyclosporin A treatment | CyA | 1.3 | Infected | X | X |
S-Hepcidin | Hepc | 1.3 | Infected | X | X |
B-Mean corpuscular hemoglobin concentration | MCHC | 1.3 | Infected | X | X |
B-Eosinophil count | Eos | 1.3 | Non-infected | X | |
S-Alpha fetoprotein | AFP | 1.3 | Infected | X | X |
S-Lactate dehydrogenase | LD | 1.3 | Non-infected | X | |
Blood pressure (diastolic) | BPd | 1.3 | Non-infected | X | X |
S-Cholesterol | Chol | 1.3 | Non-infected | X | X |
B-Reticulocyte count | Ret | 1.3 | Non-infected | X | X |
S-Immunoglobulin E | IgE | 1.3 | Non-infected | X | |
Peripheral vein sampling | Per | 1.2 | Non-infected | X | X |
Port-a-catheter | PAC | 1.2 | Infected | X | X |
S-Interleukin-1 | IL-1 | 1.2 | Infected | X | X |
B-Mean corpuscular volume | MCV | 1.2 | Non-infected | X | X |
B-International Normalized Ratio ( = prothrombin time) | INR | 1.2 | Infected | X | X |
P-Factor X | X | 1.2 | Non-infected | X | X |
B-Monocyte count | Mono | 1.2 | Non-infected | X | |
S-C-reactive protein | CRP | 1.2 | Infected | X | X |
S-Ferritin | Ferri | 1.1 | Infected | X | |
S-Potassium | K | 1.1 | Infected | X | |
S-Hemopexin | Hpx | 1.1 | Non-infected | X | |
S-Troponin T | TropT | 1.1 | Infected | X | X |
B-Hemoglobin A | HbA | 1.1 | Non-infected | X | |
S-Transferrin | Trans | 1.1 | Non-infected | X | X |
S-Immunoglobulin M | IgM | 1.0 | Infected | X | |
S-Sodium | Na | 1.0 | Non-infected | X | X |
B-Basophil count | Bas | 1.0 | Non-infected | X | |
B-Erythrocyte particle concentration | EPC | 1.0 | Non-infected | X | X |
S-Orosomucoid | Oro | 1.0 | Non-infected | X | |
P-Activated partial thromboplastin time | APTT | 1.0 | Infected | X | X |
S-Thyroid stimulatory hormone | TSH | 1.0 | Non-infected | X | |
S-Total iron binding capacity | TIBC | 1.0 | Non-infected | X | X |
Allogeneic transplant recipient | Allo | 0.97 | |||
P-Coagulation factor II (prothrombin) | II | 0.96 | |||
Erythrocyte sedimentation rate | SR | 0.91 | |||
S-High density lipoprotein | HDL | 0.88 | |||
S-Chloride | Cl | 0.85 | |||
S-Amylase, pancreatic | AmyP | 0.83 | |||
S-Alanine aminotransferase | ALT | 0.81 | |||
S-Immunoglobulin G | IgG | 0.79 | |||
S-Albumin | Alb | 0.79 | |||
B-Platelet count | PC | 0.78 | |||
P-Coagulation factor VII | VII | 0.72 | |||
S-Testosterone | Test | 0.71 | |||
S-Interleukin-6 | IL-6 | 0.70 | |||
S-Triiodothyronine | T3 | 0.69 | |||
S-Creatinine | Crea | 0.68 | |||
S-Leptin | Lep | 0.68 | |||
S-Myoglobin | Myo | 0.67 | |||
Blood pressure, systolic | BPs | 0.67 | |||
S-Tetraiodothyronine | T4 | 0.67 | |||
S-Tumor necrosis factor | TNF | 0.65 | |||
S-Estrogen | Est | 0.65 | |||
S-Protein | Prot | 0.64 | |||
Patient fasting prior to blood sampling | Fast | 0.63 | |||
S-Creatine kinase, muscle brain | CKM | 0.63 | |||
S-Transferrin saturation | TransS | 0.60 | |||
P-Factor XI | XI | 0.60 | |||
S-Triglycerides | TG | 0.60 | |||
S-α2-macroglobulin | a2M | 0.59 | |||
S-Aspartate aminotransferase | AST | 0.59 | |||
S-Soluble transferrin receptor | TfR | 0.57 | |||
Body length | Leng | 0.56 | |||
P-Protein C | ProtC | 0.55 | |||
Cytarabine treatment, current | Cytar | 0.53 | |||
S-Iron | Fe | 0.52 | |||
No of fever days prior to inclusion | Fday | 0.52 | |||
S-Urate | Urate | 0.52 | |||
S-Insulin growth factor-1 | IGF-1 | 0.51 | |||
Peripheral vein catheter | PVC | 0.50 | |||
S-Ceruloplasmin | Cer | 0.49 | |||
Body weight | Wt | 0.48 | |||
S-Phosphate | P | 0.48 | |||
S-Haptoglobin | Hap | 0.47 | |||
P-Factor VIII | VIII | 0.47 | |||
S-Immunoglobulin A | IgA | 0.47 | |||
Autologous transplant recipient | Auto | 0.47 | |||
S-Alkaline phosphatase | ALP | 0.46 | |||
Heart rate | HR | 0.45 | |||
B-Erythrocyte mean corpuscular hemoglobin | MCH | 0.44 | |||
P-Coagulation factor V | V | 0.39 | |||
S-Tetratiodothyronine, free | T4f | 0.39 | |||
S-Adiponectin | Adip | 0.38 | |||
S-Prostate specific antigen, free | PSAf | 0.37 | |||
S-γ-Glutamyl transferase | gGT | 0.32 | |||
P-Dimerized plasmin fragment D | Dim | 0.32 | |||
S-Thyroxin-binding globulin | TBG | 0.32 | |||
Age | Age | 0.28 | |||
P-Erythropoietin | EPO | 0.27 | |||
Central venous catheter | CVC | 0.27 | |||
S-Interferon-γ | IFNg | 0.27 | |||
S-Triiodothyronine, free | T3f | 0.26 | |||
Hypogammaglobulinemia | Hypog | 0.26 | |||
S-Calcium | Ca | 0.25 | |||
S-Amyloid A | SAA | 0.24 | |||
S-Fibrinogen | Fibrino | 0.24 | |||
Temperature | Temp | 0.22 | |||
Presence of chills | Chills | 0.20 | |||
Peripheral oxygen saturation | POX | 0.19 | |||
S-Interleukin-17 | IL-17 | 0.19 | |||
S-C4b-binding protein-α chain | C4BPa | 0.18 | |||
S-Complement factor 3 | C3 | 0.17 | |||
Sex | Sex | 0.16 | |||
S-Lactoferrin | Lact | 0.16 | |||
P-anti-thrombin | a-thrombin | 0.14 | |||
S-Amylase, total | AmyT | 0.14 | |||
S-Creatine kinase | CK | 0.14 | |||
S-Magnesium | Mg | 0.14 | |||
S-Prostate-specific antigen | PSA | 0.093 | |||
S-Total complement complex | TCC | 0.076 | |||
Corticosteroid therapy | Co | 0.066 | |||
P-Renin | Ren | 0.056 | |||
S-α1-antitrypsin | AT | 0.032 | |||
S-Complement factor 4 | C4 | 0.025 | |||
S-NT pro-brain natriuretic peptide | pBNP | 0.015 | |||
P-Factor IX | IX | 0.0051 |
Abbreviations: S = serum, P = blood plasma, B = blood.
The relative importance of each variable to the 139-variable model was determined using the “Variable importance” module in the SIMCA software.
Patients were classified as infected or non-infected by an independent infectious disease specialist blinded to the results of the biochemical analyses